3) Previous target trial emulations have assumed no unobserved confounding. While we found that this is a plausible assumption amongst the RCT-eligible subpopulation, our results suggest that this assumption is likely implausible for the RCT-ineligible subpopulation

English

110

David Lugo Palacios@dlugopal·27 Eyl

2) We assess the performance of a local #IV approach vs a published RCT and explore essential heterogeneity across an entire target population, including subpopulations who met RCT eligibility criteria and those who did not

English

125

David Lugo Palacios@dlugopal·27 Eyl

New @LSHTM_GHECO + @Basucally + @DrAmandaAdler + @karlado paper on @HECJournalTweet! We used target trial emulation with local #IVs to examine treatment effect heterogeneity across subpopulations eligible and ineligible for a published RCT onlinelibrary.wiley.com/doi/10.1002/he…

English

1.9K

David Lugo Palacios@dlugopal·15 May

@jd_wilko A bit of self-promotion here, but sharing the link to the SAP from our #PERMIT study. Hope it's helpful! #design-and-analysis-plan" target="_blank" rel="nofollow noopener">lshtm.ac.uk/research/centr…

English

191

David Lugo Palacios@dlugopal·14 May

Our research showing how #IV methods can help inform clinical practice @pbidulka @CarrollOrlagh @Basucally @DrAmandaAdler @kamleshkhunti @SONeill1999 @RJ_Silverwood @TheStatsGeek @LiamSmeeth1

The BMJ@bmj_latest

This research in @bmj_latest compared the effectiveness of three antidiabetic drugs for people with type 2 #diabetes mellitus. SGLT-2 inhibitors were more effective second line treatments compared with DPP-4 inhibitors or sulfonylureas, @pbidulka bmj.com/content/385/bm…

English

1.4K

David Lugo Palacios@dlugopal·8 May

New @LSHTM_GHECO paper on @bmj_latest ! We assessed the comparative effectiveness of 3 second line antidiabetics by emulating a target trial with #IVs and electronic health records bmj.com/content/385/bm…

English

1.9K

David Lugo Palacios@dlugopal·2 May

@HealthEcon_Will Congrats, Will! All the best!!

English

Will Whittaker@HealthEcon_Will·1 May

Excited to announce I’m joining University of Liverpool in July 😃 I’ve had an amazing time and had outstanding opportunities at University of Manchester and MCHE but a new journey awaits! 🌅

English

1.1K

David Lugo Palacios@dlugopal·21 Nis

@raulpacheco @EGobiernoyTP @LSHTM_GHECO Claro! Avísame si te das una vuelta y coordinamos!

Español

Dr Raul Pacheco-Vega@raulpacheco·21 Nis

@dlugopal @EGobiernoyTP @LSHTM_GHECO Uy qué mal. Yo regreso mañana muy noche. Espero verte en Londres en algún momento!

Español

David Lugo Palacios@dlugopal·20 Nis

Muy agradecido por la invitación de la @EGobiernoyTP para presentar un trabajo con colegas de @LSHTM_GHECO utilizando #targettrials y #LocalIV para estimar efectos de tratamiento heterogéneos

Escuela de Gobierno@EGobiernoyTP

Hoy, @dlugopal, de @LSHTM, presentó estudio que muestra cómo los métodos de variable instrumental local (VIL) pueden proporcionar evidencia útil sobre la heterogeneidad del efecto de tratamientos médicos, incluyendo variables no observables. #FormamosElFuturo

Español

1.6K

David Lugo Palacios@dlugopal·21 Nis

@raulpacheco @EGobiernoyTP @LSHTM_GHECO Sí! Aunque ya estoy por salir de regreso a UK...

Español

Dr Raul Pacheco-Vega@raulpacheco·21 Nis

@dlugopal @EGobiernoyTP @LSHTM_GHECO Andas en CDMX!?

English

David Lugo Palacios@dlugopal·21 Nis

@hectorjuanvp @EGobiernoyTP @LSHTM_GHECO Muchas gracias, Héctor! Disfruté mucho la visita, las preguntas y la discusión que tuvimos ayer.

Español

Héctor J. Villarreal@hectorjuanvp·20 Nis

@dlugopal @EGobiernoyTP @LSHTM_GHECO Fue un gusto David, muy interesante (y prometedor) lo que están haciendo.

Español

David Lugo Palacios@dlugopal·26 Oca

@mr_nunal Gracias, Alberto! Un abrazo!

Español

Alberto Nunez@mr_nunal·25 Oca

Come and work with @dlugopal and his teammates. They are very nice and friendy research group and work in very interesting and important topics in health economics. You will learn a lot and meanwhile you will have fun.

David Lugo Palacios@dlugopal

There are two vacancies in our team for health economists/data scientists/statisticians! Join us!! @LSHTM_GHECO jobs.lshtm.ac.uk/vacancy.aspx?r… jobs.lshtm.ac.uk/vacancy.aspx?r…

English

172

David Lugo Palacios@dlugopal·25 Oca

There are two vacancies in our team for health economists/data scientists/statisticians! Join us!! @LSHTM_GHECO jobs.lshtm.ac.uk/vacancy.aspx?r… jobs.lshtm.ac.uk/vacancy.aspx?r…

Global Health Economics Centre@LSHTM_GHECO

📢 @LSHTM is hiring two Research Fellows in #HealthEconomics/medical statistics/data science. Join our vibrant team, working with leading health economists, clinicians & statisticians, to advance quants methods & answer major policy questions. 5 Feb ⏰ bit.ly/3Old55Z

English

David Lugo Palacios retweetledi

Javier “Chicharito” Hernández@CH14_·24 Oca

Mi casa, mi familia, mi equipo, mi todo. Nos vemos pronto! @Chivas

Español

739

5.6K

32.7K

1.4M

David Lugo Palacios@dlugopal·25 Oca

He's coming home!! 🐐 #HO14CHICHARITO @Chivas

Manchester United@ManUtd

Always classy, Sir Alex 🫶 A heartfelt message for @CH14_ ahead of his return to his hometown club @Chivas 🇲🇽 #MUFC || #HO14CHICHARITO

English

334

David Lugo Palacios@dlugopal·4 Ara

It's my very big pleasure to share the fantastic news that @lkovacevic1 has successfully passed her PhD viva earlier today! Congrats Dr Kovacevic! Massive thanks to @HealthEcon_Will and Brendan Delaney for examining and facilitating a really interesting discussion!!

English

1.1K

Keşfet

@iacs_aragon @MattXSutton @LSHTM @LSHTM_GHECO @Basucally @DrAmandaAdler @karlado @pbidulka